source
- Nordic biotech must unite to become a global force, say venture investorsThe latest episode of BioSpace's podcast Denatured features Ester Sklarsky of Sound Bioventures and João Ribas of Novo Holdings Seed Investments discussing the future of Nordic biotech. The guests…
- AstraZeneca’s rare disease drug Wainua fails Phase 3, narrowing path to $80 billion sales goalAstraZeneca announced that its rare disease therapy Wainua did not meet its primary endpoints in a Phase 3 trial, ending plans to broaden the drug’s label for transthyretin amyloidosis cardiomyopat…